Retour
Fourchette du Jour
6,99 €
7,39 €
Fourchette 52 Semaines
2,41 €
8,72 €
Volume
941 058
Moyenne 50J / 200J
6,41 €
/
5,73 €
Clôture Précédente
7,03 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,2 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | -109,9 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -157,44M
PEG of 0,08 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-109,90%
ROIC-66,81%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,12
Current Ratio6,14
Interest Coverage0,00
Valorisation
P/E Ratio
-3,19
P/B Ratio3,09
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -174,33M |
| ROE | -109,90% | ROA | -74,97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157,44M |
| ROIC | -66,81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,14 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,19 | P/B Ratio | 3,09 |
| P/S Ratio | N/A | PEG Ratio | 0,08 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 556,28M | Enterprise Value | 517,54M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 8,09M | 13,62M |
| Net Income | -174,33M | -124,70M | -96,02M | -85,98M | -72,19M |
| EPS (Diluted) | -1,99 | -3,06 | -4,83 | -10,10 | -10,14 |
| Gross Profit | -1,64M | -2,46M | -2,58M | 8,09M | 13,62M |
| Operating Income | -179,21M | -129,73M | -104,32M | -106,45M | -72,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 232,54M | 188,66M | 164,94M | 260,25M | 232,38M |
| Total Liabilities | 52,53M | 51,42M | 38,46M | 48,59M | 24,17M |
| Shareholders' Equity | 180,01M | 137,25M | 126,48M | 211,67M | 208,21M |
| Total Debt | 21,16M | 24,18M | 26,27M | 28,55M | 2,06M |
| Cash & Equivalents | 59,90M | 80,24M | 74,02M | 155,38M | 119,14M |
| Current Assets | 205,46M | 157,30M | 129,73M | 219,64M | 222,61M |
| Current Liabilities | 33,47M | 30,26M | 14,52M | 22,51M | 23,60M |